Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $278,491 | 61 | 75.7% |
| Travel and Lodging | $29,410 | 32 | 8.0% |
| Unspecified | $25,511 | 15 | 6.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,847 | 11 | 5.4% |
| Food and Beverage | $11,556 | 178 | 3.1% |
| Honoraria | $3,000 | 1 | 0.8% |
| Grant | $121.00 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $200,505 | 44 | $0 (2021) |
| Astellas Pharma Global Development | $31,672 | 15 | $0 (2020) |
| UROVANT SCIENCES INC | $27,108 | 12 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $19,369 | 10 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $18,317 | 9 | $0 (2018) |
| Astellas Pharma US Inc | $17,126 | 13 | $0 (2018) |
| Laborie Medical Technologies Corp. | $7,125 | 3 | $0 (2022) |
| Hologic, LLC | $6,875 | 5 | $0 (2020) |
| Axonics, Inc. | $5,564 | 14 | $0 (2024) |
| Medtronic, Inc. | $5,008 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,932 | 29 | Sumitomo Pharma America, Inc. ($4,059) |
| 2023 | $17,427 | 20 | Sumitomo Pharma America, Inc. ($15,310) |
| 2022 | $29,921 | 66 | UROVANT SCIENCES INC ($18,258) |
| 2021 | $25,786 | 21 | UROVANT SCIENCES INC ($8,850) |
| 2020 | $89,242 | 27 | Allergan, Inc. ($77,594) |
| 2019 | $111,300 | 41 | Allergan Inc. ($103,757) |
| 2018 | $61,725 | 63 | Merck Sharp & Dohme Corporation ($18,317) |
| 2017 | $24,602 | 32 | Astellas Pharma Global Development ($15,381) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/13/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/11/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $149.89 | General |
| Category: Urology | ||||||
| 09/14/2024 | Avation Medical, Inc. | Vivally (Device) | Food and Beverage | Cash or cash equivalent | $6.59 | General |
| Category: Device | ||||||
| 09/13/2024 | Avation Medical, Inc. | Vivally (Device) | Food and Beverage | Cash or cash equivalent | $168.95 | General |
| Category: Device | ||||||
| 07/10/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: UROLOGY | ||||||
| 07/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: UROLOGY | ||||||
| 06/28/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $144.77 | General |
| Category: UROLOGY | ||||||
| 06/19/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $94.36 | General |
| 06/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: UROLOGY | ||||||
| 06/11/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $217.56 | General |
| Category: UROLOGY | ||||||
| 05/31/2024 | Provepharm Inc. | BLUDIGO (Drug) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: MARKER DYE | ||||||
| 05/22/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $387.50 | General |
| 05/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: UROLOGY | ||||||
| 05/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $125.00 | General |
| Category: UROLOGY | ||||||
| 05/04/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $88.85 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $122.00 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: UROLOGY | ||||||
| 05/02/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $124.24 | General |
| Category: BLADDER | ||||||
| 04/30/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $91.51 | General |
| Category: Urology | ||||||
| 04/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $142.18 | General |
| Category: General - Female SUI_URO | ||||||
| 03/06/2024 | Boston Scientific Corporation | AdVance XP (Device) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: AdVance_URO | ||||||
| 03/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $93.60 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 03/01/2024 | 180 Medical, Inc. | GENTLECATH GLIDE (Device) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: CONTINENCE CARE | ||||||
| 02/27/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $138.44 | General |
| Category: Urology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder OAB | Astellas Pharma Global Development | $8,303 | 7 |
| A Prospective, Non-Interventional, Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder (OAB) | Astellas Pharma Global Development | $4,106 | 1 |
| Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder OAB | Astellas Pharma Global Development | $3,195 | 1 |
| A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder OAB | Astellas Pharma Global Development | $3,195 | 1 |
| TITAN 2 | Medtronic, Inc. | $3,144 | 2 |
| Penguin | Cytyc Surgical Products, LLC | $1,971 | 1 |
| A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder OAB PERSPECTIVE | Astellas Pharma Global Development | $798.83 | 1 |
| A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) | Astellas Pharma Global Development | $798.67 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,768 | 1,972 | $948,814 | $119,541 |
| 2022 | 17 | 2,024 | 2,282 | $1.0M | $142,001 |
| 2021 | 23 | 2,249 | 2,599 | $1.2M | $158,012 |
| 2020 | 21 | 2,200 | 2,500 | $974,113 | $127,734 |
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 3 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 51600 | Injection procedure for imaging of bladder during voiding | Facility | 2022 | 35 | 35 | $18,396 | $498.69 | 2.7% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Facility | 2022 | 36 | 36 | $13,932 | $496.05 | 3.6% |
| 51701 | Insertion of temporary bladder tube | Facility | 2022 | 21 | 22 | $11,792 | $412.28 | 3.5% |
| 74455 | Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | Facility | 2022 | 35 | 35 | $6,965 | $404.36 | 5.8% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Facility | 2022 | 12 | 12 | $7,944 | $374.07 | 4.7% |
| 51705 | Simple change of bladder tube | Facility | 2022 | 11 | 16 | $7,904 | $348.62 | 4.4% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2022 | 79 | 89 | $25,009 | $345.30 | 1.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 194 | 262 | $56,820 | $24,258 | 42.7% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 117 | 131 | $86,591 | $19,879 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 141 | 172 | $37,532 | $12,463 | 33.2% |
| 51728 | Complex measurement of pressure of urine flow in bladder (cystometrogram) with voiding pressure studies | Office | 2021 | 46 | 46 | $69,322 | $12,349 | 17.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 82 | 82 | $26,634 | $9,312 | 35.0% |
| 52601 | Electro-removal of prostate through bladder canal (urethra) with control of bleeding using an endoscope | Facility | 2021 | 16 | 16 | $92,672 | $8,904 | 9.6% |
| 52287 | Examination with injections of chemical for destruction of bladder using an endoscope | Facility | 2021 | 56 | 70 | $94,360 | $7,950 | 8.4% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Office | 2021 | 52 | 52 | $32,604 | $7,433 | 22.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 98 | $15,598 | $6,157 | 39.5% |
| 64581 | Incision to insert sacral nerve neurostimulator electrodes | Facility | 2021 | 11 | 11 | $34,023 | $5,528 | 16.2% |
| 51728 | Complex measurement of pressure of urine flow in bladder (cystometrogram) with voiding pressure studies | Facility | 2021 | 58 | 59 | $39,884 | $4,553 | 11.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 93 | 100 | $15,836 | $4,515 | 28.5% |
| 74455 | Radiological supervision and interpretation x-ray of urinary bladder and urethra, emptying | Office | 2021 | 54 | 54 | $51,138 | $4,308 | 8.4% |
| 51600 | Injection procedure for x-ray imaging of the bladder or during voiding | Office | 2021 | 48 | 48 | $23,616 | $4,015 | 17.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 44 | 44 | $14,268 | $3,927 | 27.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 70 | 73 | $48,253 | $3,434 | 7.1% |
| 51715 | Injection of implant material beneath lining of bladder and/or bladder canal (urethra) using endoscope | Facility | 2021 | 14 | 18 | $45,018 | $2,811 | 6.2% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Facility | 2021 | 63 | 64 | $16,768 | $1,921 | 11.5% |
About Dr. Eric Rovner, MD
Dr. Eric Rovner, MD is a Urology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841237013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Rovner, MD has received a total of $367,935 in payments from pharmaceutical and medical device companies, with $7,932 received in 2024. These payments were reported across 299 transactions from 36 companies. The most common payment nature is "Consulting Fee" ($278,491).
As a Medicare-enrolled provider, Rovner has provided services to 8,241 Medicare beneficiaries, totaling 9,353 services with total Medicare billing of $547,289. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urogynecology and Reconstructive Pelvic Surgery
- Location Charleston, SC
- Active Since 05/31/2006
- Last Updated 10/20/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1841237013
Products in Payments
- BOTOX (Drug) $77,117
- BOTOX (Biological) $71,639
- GEMTESA (Drug) $44,202
- BOTOX COSMETIC (Biological) $24,039
- MIRABEGRON (Drug) $20,606
- Myrbetriq (Drug) $15,381
- MYRBETRIQ (Drug) $12,810
- MK-7264 (Drug) $7,150
- Axonics r-SNM System (Device) $5,402
- Noctiva (Drug) $4,516
- BOTOX THERAPEUTIC - HH (Biological) $4,176
- NOCDURNA (Drug) $3,000
- INTERSTIM (Device) $2,568
- RENOVA $2,378
- BLUDIGO (Drug) $1,600
- eCoin Device Kit (Device) $894.70
- ACT (Device) $736.00
- Axonics (Device) $724.76
- Bulkamid (Device) $584.17
- AQUABEAM ROBOTIC SYSTEM (Device) $575.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Charleston
Dr. Sandip Prasad, Md, Mphil, MD, MPHIL
Urology — Payments: $102,389
Dr. Ian Marshall, M. D, M. D
Urology — Payments: $71,598
Dr. Thomas Keane, Md, MD
Urology — Payments: $70,386
Stephen Savage, Md, MD
Urology — Payments: $29,716
John Adams, Md, MD
Urology — Payments: $21,374
Dr. John Britton, M. D, M. D
Urology — Payments: $15,500